About Us

Chengdu Seamaty Technology Co.,Ltd

We focus on the development, production, and sales of in vitro diagnostic POCT (bedside diagnosis) reagents and instruments

8,000,000-10,000,000
Annual Revenue
200~230
Employees
2012
Year Established
Manufacturer, Exporter, Seller
Business Type

The mission of Seamaty is to bring diagnosis closer to the patient, not only by way of point of care but also more affordable. Our mission also resonates with our company value of constantly striving to be closer to our internal and external partners.

 

The founder of Seamaty, Mr. Peng Ran, has been involved with the analyzer development from inception stages and never gave up on fulfilling the development brief. He had a real passion for and an obligation towards bringing this brand new experience in point of care diagnostics to the global primary healthcare sector.

 

Following years of development, ensuring the best quality product, Seamaty launched its first easy to use, quick, accurate and cost-effective fully automated point of care biochemistry analyzer. This was followed with the development of the veterinary version for our close companions, to bring the same innovation to their healthcare.

 

Seamaty is accredited as a high-tech enterprise and holds an ISO13485:2015 quality management system for medical device manufacturing certification issue by TUV. All Seamaty products are CE listed

China CE
CE
15089367 001
China EC declaration of Conformity
EC declaration of Conformity
15089367 001
China ISO 13485:2012
ISO 13485:2012
SX 60127420 0001
China ISO 13485:2012
ISO 13485:2012
SX 60127420 0001